Andrea Ellis, Director at BridgeBio Pharma, Inc. (BBIO), bought 12,000 shares at $8.39 ($101K) on 2022-03-15, disclosed to the SEC on 2022-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BBIO | SELL | 2025-08-07 | $841K | — | Filing → |
| BBIO | SELL | 2025-04-16 | $350K | — | Filing → |
| BBIO | SELL | 2025-04-03 | $2.0M | — | Filing → |